{
    "medicine_id": "3299aa33fbd29afeb27411360a21404a19e73415",
    "platform_id": "DB03516",
    "metadata": {
        "name": "Panhematin 7 mg 1mL Powder for solution",
        "composition": "7 mg 1mL Eniluracil",
        "clinical_particulars": {
            "therapeutic_indications": "For the treatment of cancer in combination with 5 fluorouracil",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Eniluracil is an orally active dihydropyrimidine dehydrogenase DPD inhibitor designed to enhance activity of chemotaxic agents It is under investigation by Adherex under license from GlaxoSmithKline for the treatment of cancer in combination with 5 fluorouracil 5 FU",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}